- Q1 2024 Ligand Pharmaceuticals Inc Earnings Call TranscriptMay 07, 2024$73.22 (+0.54%)Earnings
- Q4 2023 Ligand Pharmaceuticals Inc Earnings Call TranscriptFeb 27, 2024$89.2 (+19.86%)Earnings
- Ligand Pharmaceuticals Inc To Host Investor Day TranscriptDec 12, 2023
- Q3 2023 Ligand Pharmaceuticals Inc Earnings Call TranscriptNov 08, 2023$52.23 (-1.75%)Earnings
- Q2 2023 Ligand Pharmaceuticals Inc Earnings Call TranscriptAug 08, 2023$67.13 (+1.25%)Earnings
- Q1 2023 Ligand Pharmaceuticals Inc Earnings Call TranscriptMay 04, 2023$76.71 (+1.70%)Earnings
- Q4 2022 Ligand Pharmaceuticals Inc Earnings Call TranscriptFeb 22, 2023$72.12 (+1.75%)Earnings
- Ligand Pharmaceuticals Inc Investor and Analyst Day TranscriptDec 13, 2022
- Q3 2022 Ligand Pharmaceuticals Inc Earnings Call TranscriptNov 07, 2022$62.84 (+1.35%)Earnings
- Q2 2022 Ligand Pharmaceuticals Inc Earnings Call TranscriptAug 08, 2022$61.89 (+2.18%)Earnings
- Ligand Pharmaceuticals Inc Annual Shareholders Meeting TranscriptJun 10, 2022
- Q1 2022 Ligand Pharmaceuticals Inc Earnings Call TranscriptMay 04, 2022$59.86 (+2.77%)Earnings
- Q4 2021 Ligand Pharmaceuticals Inc Earnings Call TranscriptFeb 17, 2022$69.97 (-8.43%)Earnings
- Q3 2021 Ligand Pharmaceuticals Inc Earnings Call TranscriptNov 09, 2021$94.71 (-1.26%)Earnings
- Q2 2021 Ligand Pharmaceuticals Inc Earnings Call TranscriptJul 29, 2021$74.18 (-3.64%)Earnings
- Ligand Pharmaceuticals Inc Annual Shareholders Meeting TranscriptJun 04, 2021
- Q1 2021 Ligand Pharmaceuticals Inc Earnings Call TranscriptMay 03, 2021$90.56 (-0.45%)Earnings
- Q4 2020 Ligand Pharmaceuticals Inc Earnings Call TranscriptFeb 03, 2021$110.68 (+0.24%)Earnings
- Ligand Pharmaceuticals Inc Extraordinary Shareholders Meeting TranscriptDec 15, 2020
- Q3 2020 Ligand Pharmaceuticals Inc Earnings Call TranscriptOct 30, 2020$51.41 (-0.75%)Earnings
- Ligand Pharmaceuticals Inc Virtual Investor Day TranscriptOct 20, 2020
- Q2 2020 Ligand Pharmaceuticals Inc Earnings Call TranscriptAug 03, 2020$74.25 (+1.62%)Earnings
- Ligand Pharmaceuticals Inc Annual Shareholders Meeting TranscriptJun 10, 2020
- Q1 2020 Ligand Pharmaceuticals Inc Earnings Call TranscriptMay 06, 2020$63.29 (+1.61%)Earnings
- Ligand Pharmaceuticals Inc at Barclays Global Healthcare Conference TranscriptMar 10, 2020
- Q4 2019 Ligand Pharmaceuticals Inc Earnings Call TranscriptFeb 06, 2020$57.67 (+0.31%)Earnings
- Q3 2019 Ligand Pharmaceuticals Inc Earnings Call TranscriptNov 05, 2019$69.67 (+1.27%)Earnings
- Q2 2019 Ligand Pharmaceuticals Inc Earnings Call TranscriptJul 30, 2019$59.38 (-11.38%)Earnings
- Q1 2019 Ligand Pharmaceuticals Inc Earnings Call TranscriptMay 02, 2019$79.26 (+1.10%)Earnings
- Ligand Pharmaceuticals Inc at Barclays Global Healthcare Conference TranscriptMar 13, 2019
- Ligand Pharmaceuticals Inc Analyst Day TranscriptMar 12, 2019
- Ligand Pharmaceuticals Inc Announce Sale of Promacta Assets and Royalty to Royalty Pharma Call TranscriptMar 05, 2019
- Q4 2018 Ligand Pharmaceuticals Inc Earnings Call TranscriptFeb 07, 2019$72.66 (-0.95%)Earnings
Q1 2022 Ligand Pharmaceuticals Inc Earnings Call Transcript
Good day, everyone, and welcome to Ligand Pharmaceuticals' First Quarter '22 Earnings Call. (Operator Instructions) Please note this call may be recorded.
It is now my pleasure to turn today's program over to Simon Latimer, Head of Investor Relations. Please go ahead.
Thanks. Welcome to Ligand's first quarter of 2022 financial results and business update conference call. Our speakers for today's call are in separate locations. Speaking today for Ligand will be John Higgins, CEO; Matt Foehr, COO; and Matt Korenberg, CFO.
We'll use non-GAAP financial measures and some of our statements will be forward looking, including those relating to our financial condition, results of operations, financial guidance, the impact of the COVID-19 pandemic, and the expected timing completion effects of our previously announced plans to spin-off the OmniAb business to become a standalone public company pursuant to a business combination with the Avista Public Acquisition Corp. II.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)